ADD CONDITION

items per page

Lamisil at Cream

Last content change checked dailysee data sync status

Active ingredient
Terbinafine Hydrochloride 1 g/100 g
Other brand names
Drug class
Allylamine Antifungal
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2020
Label revision date
November 18, 2025
Active ingredient
Terbinafine Hydrochloride 1 g/100 g
Other brand names
Drug class
Allylamine Antifungal
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2020
Label revision date
November 18, 2025
Manufacturer
Voyant Beauty Inc.
Registration number
NDA020980
NDC root
61047-120

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Lamisil AT is a topical cream that contains terbinafine hydrochloride, an antifungal medication. It is primarily used to treat common fungal skin infections such as jock itch (tinea cruris) and ringworm (tinea corporis). This cream works by curing the infection and providing relief from uncomfortable symptoms like itching, burning, cracking, and scaling associated with these conditions.

If you're dealing with jock itch or ringworm, Lamisil AT can help alleviate your discomfort and promote healing. The cream is easy to apply and is designed to effectively target the source of the infection, allowing you to feel more comfortable in your skin.

Uses

If you're dealing with jock itch (tinea cruris) or ringworm (tinea corporis), this treatment can help. It effectively cures most cases of these fungal infections, allowing you to get back to your daily activities without discomfort.

In addition to treating the infection, it also provides relief from the annoying symptoms that often come with these conditions, such as itching, burning, cracking, and scaling. You can expect a more comfortable experience as the treatment works to clear up the infection and soothe your skin.

Dosage and Administration

To use this medication effectively, start by breaking the seal on the tube with the tip of the cap. Before applying the medication, wash the affected area of your skin with soap and water, then dry it completely. If you're treating athlete's foot, it's important to wear well-fitting, ventilated shoes and change your shoes and socks at least once a day.

For treating athlete's foot, apply the medication twice a day—once in the morning and once at night—for one week if you're applying it between the toes. If you're applying it to the bottom or sides of your foot, continue this twice-daily application for two weeks. For jock itch and ringworm, you only need to apply the medication once a day, either in the morning or at night, for one week. Remember to wash your hands after each use. If the patient is a child under 12 years old, consult a doctor before use.

What to Avoid

It's important to use this product safely and effectively. You should avoid applying it to your nails or scalp, and it should not be used in or near your mouth or eyes. Additionally, this product is not intended for treating vaginal yeast infections, so please refrain from using it for that purpose.

By following these guidelines, you can help ensure your safety and the best possible outcome from your treatment. If you have any questions or concerns, don't hesitate to reach out to a healthcare professional for guidance.

Side Effects

This product is intended for external use only, so it's important to avoid applying it to your nails or scalp, and keep it away from your mouth and eyes. If you accidentally get it in your eyes, rinse thoroughly with water.

While using this product, if you experience excessive irritation or if your symptoms worsen, stop using it and consult a doctor. Additionally, keep this product out of reach of children. If swallowed, seek medical help or contact a Poison Control Center immediately.

Warnings and Precautions

This product is intended for external use only, so please avoid applying it to your nails or scalp, and do not use it in or near your mouth or eyes. It is also not suitable for treating vaginal yeast infections. If the product accidentally gets into your eyes, rinse them thoroughly with water.

While using this product, if you experience excessive irritation or if the irritation worsens, stop using it and consult your doctor. Always keep this product out of reach of children. If it is swallowed, seek medical help or contact a Poison Control Center immediately.

Overdose

It's important to keep this medication out of reach of children. If a child accidentally swallows it, you should seek medical help or contact a Poison Control Center immediately.

In case of an overdose, you may notice symptoms such as unusual drowsiness, confusion, or difficulty breathing. If you or someone else experiences these signs, it's crucial to get emergency assistance right away. Always prioritize safety and act quickly in these situations.

Pregnancy Use

When considering the use of LAMISIL AT CREAM (terbinafine hydrochloride cream) during pregnancy, it's important to note that there is no specific information available about its safety, dosage adjustments, or any special precautions for pregnant individuals. This means that the effects of this medication on pregnancy have not been clearly studied or established.

If you are pregnant or planning to become pregnant, it is always best to consult with your healthcare provider before using any medication, including LAMISIL AT CREAM. They can help you weigh the potential risks and benefits based on your individual situation.

Lactation Use

If you are breastfeeding, it's important to consult your doctor before using this product. There is a possibility that it may be excreted in breast milk, which means it could potentially affect your nursing infant. Because there are no specific studies on how this product impacts breastfeeding, it's best to exercise caution when considering its use while nursing. Always prioritize your health and your baby's well-being by discussing any concerns with your healthcare provider.

Pediatric Use

If you are considering this medication for your child, it's important to know that children under 12 years old should consult a doctor before use. This ensures that the treatment is safe and appropriate for their age and health needs. For adults and children aged 12 years and older, there are specific dosing instructions available that you should follow carefully to ensure effective and safe use. Always prioritize your child's health by seeking professional guidance when needed.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

It appears that there is no specific information regarding renal impairment (kidney problems) in the provided text. Therefore, there are no dosage adjustments, special monitoring, or safety considerations to discuss for patients with kidney issues. If you have concerns about how your kidney health may affect your treatment, it's important to consult your healthcare provider for personalized advice and guidance.

Hepatic Impairment

If you have liver problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or precautions related to your condition. This means that there are no tailored recommendations for how the medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to ensure that any treatment plan is safe and effective for your specific situation. They can help determine the best approach based on your liver function and overall health.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you. Always share your complete list of medications and any health conditions you have to receive the best care possible.

Storage and Handling

To ensure the safety and effectiveness of your product, always check that the seal on the tube is intact and visible before use. If the seal is broken, do not use the product.

For proper storage, keep the product at a controlled room temperature between 20-25°C (68-77°F). This helps maintain its quality and performance. Following these guidelines will help you use the product safely and effectively.

Additional Information

No further information is available.

FAQ

What is Lamisil AT?

Lamisil AT is a cream containing Terbinafine Hydrochloride 1%, used as an antifungal treatment.

What conditions does Lamisil AT treat?

It cures most jock itch (tinea cruris) and ringworm (tinea corporis), relieving associated itching, burning, cracking, and scaling.

How should I use Lamisil AT?

For adults and children 12 years and over, apply the cream as directed: once a day for jock itch and ringworm, or twice a day for athlete's foot, depending on the area affected.

Are there any precautions when using Lamisil AT?

Yes, do not get the cream in your eyes, and avoid using it on nails, scalp, or for vaginal yeast infections.

What should I do if I experience irritation?

Stop use and ask a doctor if too much irritation occurs or worsens.

Is Lamisil AT safe for children?

Children under 12 years should consult a doctor before use.

Can nursing mothers use Lamisil AT?

Nursing mothers should consult a doctor before using this product due to potential excretion in breast milk.

What should I do if I accidentally swallow Lamisil AT?

Keep out of reach of children and seek medical help or contact a Poison Control Center immediately if swallowed.

How should I store Lamisil AT?

Store the cream at a controlled room temperature of 20-25°C (68-77°F).

Packaging Info

Below are the non-prescription pack sizes of Lamisil at Cream (terbinafine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Lamisil at Cream.
Details

Drug Information (PDF)

This file contains official product information for Lamisil at Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the treatment of most cases of jock itch (tinea cruris) and ringworm (tinea corporis). It effectively cures these fungal infections and provides relief from associated symptoms, including itching, burning, cracking, and scaling.

Dosage and Administration

Adults and children aged 12 years and older should follow these instructions for the application of the medication. To open the tube, use the tip of the cap to break the seal. Prior to application, wash the affected skin with soap and water, ensuring it is completely dry.

For the treatment of athlete's foot, it is recommended to wear well-fitting, ventilated shoes and to change shoes and socks at least once daily. When applying the medication between the toes, it should be applied twice daily (morning and night) for a duration of 1 week, or as directed by a healthcare professional. For application on the bottom or sides of the foot, the medication should also be applied twice daily (morning and night) but for a period of 2 weeks, or as directed by a healthcare professional.

In cases of jock itch and ringworm, the medication should be applied once daily (either morning or night) for 1 week, or as directed by a healthcare professional. It is important to wash hands thoroughly after each use to prevent contamination.

For children under 12 years of age, it is advised to consult a doctor before use.

Contraindications

The product is contraindicated for use on nails or the scalp. It should not be applied in or near the mouth or eyes. Additionally, the product is not indicated for the treatment of vaginal yeast infections.

Warnings and Precautions

This product is intended for external use only. It is contraindicated for application on nails or the scalp, and it should not be used in or near the mouth or eyes. Additionally, this product is not indicated for the treatment of vaginal yeast infections.

Healthcare professionals should advise patients to avoid contact with the eyes during use. In the event of accidental eye contact, it is imperative to rinse the eyes thoroughly with water.

Patients should be instructed to discontinue use and consult a healthcare provider if they experience excessive irritation or if the irritation worsens.

To ensure safety, this product must be kept out of reach of children. In the case of ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should be aware that this product is for external use only. It is contraindicated for application on nails or the scalp, and it should not be used in or near the mouth or eyes, nor is it intended for the treatment of vaginal yeast infections.

During use, patients must take care to avoid contact with the eyes. In the event of eye contact, it is advised to rinse thoroughly with water. If irritation occurs or worsens, patients should discontinue use and consult a healthcare professional.

Additionally, this product should be kept out of reach of children. In the case of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Lamisil at Cream (terbinafine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Lamisil at Cream.
Details

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and children aged 12 years and older, specific dosing instructions are provided in the prescribing information. It is essential for healthcare providers to consider these age-related guidelines when prescribing this medication to ensure safety and efficacy in the pediatric population.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

There is no specific information available regarding the use of LAMISIL AT CREAM (terbinafine hydrochloride cream) during pregnancy. As such, the safety of this medication in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should weigh the potential benefits against any unknown risks when considering the use of this medication in women of childbearing potential. It is advisable to discuss any concerns with patients who are pregnant or planning to become pregnant.

Lactation

Lactating mothers should consult a doctor before using this product. There is a potential for excretion in breast milk. Caution is advised when using this product while breastfeeding due to the lack of specific studies on its effects on nursing infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative to keep the product out of reach of children. Should ingestion occur, immediate medical assistance is required. Healthcare professionals should advise caregivers to contact a Poison Control Center without delay.

Prompt action is crucial in managing potential overdosage situations to mitigate risks and ensure patient safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has revealed reports of the following adverse reactions: rash, pruritus, and urticaria. These events were reported voluntarily or identified through surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that this product is not intended for use on nails or the scalp, and it should not be applied in or near the mouth or eyes. Additionally, it is important to communicate that this product is not indicated for the treatment of vaginal yeast infections.

Healthcare providers should instruct patients to discontinue use and consult a doctor if they experience excessive irritation or if the irritation worsens. Furthermore, patients should be cautioned to avoid contact with the eyes while using this product. In case of eye contact, they should rinse thoroughly with water.

Storage and Handling

The product is supplied in a tube format, and it is essential to ensure that the seal on the tube is intact and visible before use. If the seal is broken or not visible, the product should not be used.

For optimal storage, the product must be kept at a controlled room temperature ranging from 20 to 25°C (68 to 77°F). Proper storage conditions are crucial to maintain the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Lamisil at Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Lamisil at Cream, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.